In vitro analysis confirmed that the secretion and/or function of these PAH‐related BMP9 mutant proteins was impaired, and BMP9 levels and activity were reduced in patient plasmas (Gräf et al., 2018; Hodgson et al., 2019; Wang et al., 2019). Here, GDF2 is linked to pulmonary arterial hypertension.